Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism  by Liu, Chunming et al.
Cell, Vol. 108, 837–847, March 22, 2002, Copyright 2002 by Cell Press
Control of -Catenin Phosphorylation/Degradation
by a Dual-Kinase Mechanism
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Four serine (S)/threonine (T) residues (S33, S37, T41,5 Center for Neuroscience and Aging
The Burnham Institute and S45) at the amino-terminal region of -catenin (Fig-
ure 1A) are conserved from Drosophila to human andLa Jolla, California 92037
conform to the consensus GSK-3 phosphorylation site
(Peifer et al., 1994). Indeed,-catenin can be phosphory-
lated by GSK-3 in vitro (Yost et al., 1996), and theseSummary
phospho-S/T residues are critical for -catenin recogni-
tion by the F box protein -Trcp, which is the specificityWnt regulation of -catenin degradation is essential
for development and carcinogenesis. -catenin deg- component of an ubiquitination apparatus (Winston et
al., 1999; Kitagawa et al., 1999; Hart et al., 1999; Latresradation is initiated upon amino-terminal serine/threo-
nine phosphorylation, which is believed to be per- et al., 1999; Liu et al., 1999). The significance of S33,
S37, T41, and S45 phosphorylation in -catenin degra-formed by glycogen synthase kinase-3 (GSK-3) in
complex with tumor suppressor proteins Axin and ad- dation is underscored by the observation that mutations
at these S/T residues frequently occur in human colo-nomatous polyposis coli (APC). Here we describe an-
other Axin-associated kinase, whose phosphorylation rectal cancer and several other malignancies (Figure
1A), which are associated with and most likely causedof -catenin precedes and is required for subsequent
GSK-3 phosphorylation of -catenin. This “priming” by deregulated accumulation of -catenin (Morin et al.,
1997; Korinek et al., 1997; Rubinfeld et al., 1997; Polakis,kinase is casein kinase I (CKI). Depletion of CKI
inhibits -catenin phosphorylation and degradation 2000). However, despite the critical importance of these
S/T phosphorylation events in regulating -catenin sta-and causes abnormal embryogenesis associated with
excessive Wnt/-catenin signaling. Our study uncov- bility, surprisingly little is known about how -catenin is
phosphorylated in vivo.ers distinct roles and steps of -catenin phosphoryla-
tion, identifies CKI as a component in Wnt/-catenin Using a panel of antibodies that specifically recognize
-catenin phosphorylated at different S/T residues, wesignaling, and has implications to pathogenesis/thera-
peutics of human cancers and diabetes. found, unexpectedly, that -catenin phosphorylation in
vivo requires CKI, whose phosphorylation of -catenin
precedes and is obligatory for subsequent GSK-3 phos-Introduction
phorylation of -catenin. Depletion of CKI prevents
-catenin phosphorylation and degradation. These find-Wnt signaling via -catenin plays a central role in devel-
opment and homeostasis (Wodarz and Nusse, 1998; ings have important implications to the understanding
of Wnt/-catenin signaling, GSK-3 and CKI function,Moon et al., 1997; Polakis, 2000). A key output of this
pathway is the level of cytosolic -catenin, which deter- and the pathogenesis and therapeutics of diseases.
mines the activation of Wnt responsive genes. Without
Wnt stimulation, -catenin is constantly degraded by Results
the proteosome (Orford et al., 1997; Aberle et al., 1997).
This degradation strictly depends upon -catenin phos- Distinct Roles and Steps of -Catenin
phorylation, which occurs in a multiprotein complex Phosphorylation
composed of tumor suppressor proteins adnomatous -catenin is recognized by -Trcp in a phosphorylation-
polyposis coli (APC), Axin, and glycogen synthase ki- dependent manner (Winston et al., 1999; Kitagawa et
nase-3 (GSK-3; Zeng et al., 1997; Behrens et al., 1998; al., 1999; Hart et al., 1999; Latres et al., 1999; Liu et
al., 1999). We showed that the -catenin (SA) mutant,
which harbors alanine substitutions at S33, S37, T41,6 Correspondence: xi.he@tch.harvard.edu
7 These authors contributed equally to this work. and S45, is not recognized by -Trcp (Liu et al., 1999).
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Figure 1. Distinct Roles and Steps of -Catenin Phosphorylation
(A) Human -catenin amino-terminal region containing S33, S37, T41, and S45. Examples of single amino acid substitutions or deletions ()
found in cancers are below the wild-type sequence.
(B) S33 and S37 phosphorylation constitutes -Trcp recognition motif. Purified GST--catenin and mutants in equal amounts were each
incubated with recombinant human GSK-3 in vitro with () or without () ATP and were then used to precipitate S35-labeled -Trcp. -catenin
was recognized by -Trcp in a phosphorylation-dependent fashion. Mutations at D32, S33, G34, or S37 abolished this recognition, whereas
mutations at T41, S45, or S23 (a control) did not. -catenin (SA) mutant, in which S33, S37, T41, and S45 were replaced by alanine, was
not bound by -Trcp.
(C) S33, S37, T41, and S45 are required for -catenin recognition by -Trcp in vivo. The wild-type or mutant -catenin (Flag-tagged) was
coexpressed in Xenopus embryos with -Trcp (Myc-tagged). The wild-type -catenin, but none of the mutants, coprecipitated -Trcp (detected
by a Myc antibody [Ab], top gel). Precipitated -catenin and mutants were detected by a Flag Ab (bottom gel). Control indicates no injection.
In the reverse precipitation, only the wild-type -catenin was coimmunoprecipitated with -Trcp (not shown).
(D) Abs for phosphorylated -catenin.
(E) Purified GST--catenin was phosphorylated by GSK-3 with or without ATP as in (B), resolved by SDS-PAGE, and immunoblotted by
indicated Abs, all of which only recognized phosphorylated -catenin. Specific phosphoresidues recognized were determined using synthetic
phosphopeptides (see Supplemental Figure S1 at http://www.cell.com/cgi/content/full/108/6/837/DC1).
(F) Differential steps and dependence of S45, T41, S37, and S33 phosphorylation in vivo. -catenin and mutants (Flag) were individually
expressed in Xenopus embryos and precipitated by a Flag Ab (bottom gel). The phosphorylation status was examined via blotting the
precipitates with indicated Abs. Mutations at either T41 or S45 abolished phosphorylation at S33 and S37 (top gel, lanes 5 and 6), but neither
mutations at S33 or S37 affected T41 or S45 phosphorylation (middle gel, lanes 3 and 4). The S45 mutation prevented T41 phosphorylation,
but the T41 mutation did not prevent S45 phosphorylation (middle gel, lanes 5 and 6). Control indicates no injection.
We thus examined how -catenin single-residue muta- -Trcp (Winston et al., 1999). Thus, phosphorylated S33
and S37, together with neighboring residues, constitutetions found in cancer cells (Figure 1A) affect its recogni-
tion by -Trcp. In a phosphorylation-coupled binding the recognition motif for -Trcp. Indeed, S33, S37, and
surrounding residues, but not T41 and S45, resembleassay in vitro (Liu et al., 1999), single-residue substitu-
tions at or surrounding S33 or S37 abolished phosphory- the -Trcp recognition motif in the transcription inhibitor
IB (Orford et al., 1997), which is also recognized andlation-dependent recognition of -catenin by -Trcp,
whereas mutations at T41 or S45 did not (Figure 1B). This degraded in a phosphorylation-dependent fashion by
-Trcp (Winston et al., 1999; Spencer et al., 1999).result is consistent with the observation that a synthetic
peptide containing phospho-S33 and -S37 binds to In contrast to these in vitro binding data, we found
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Figure 2. -Catenin Phosphorylation at T41, S37, and S33 Depends on GSK-3 and Is Regulated by Wnt Signaling, whereas S45 Phosphorylation
Requires a Distinct S45 Kinase
(A) Overexpression of GSK-3 increased phosphorylation at S33, S37 (gel 1), and T41 (gel 2) but not at S45 (gel 3) (compare lanes 1 and 2).
GSK-3KM inhibited phosphorylation at S33, S37, and T41 (gels 1 and 2) but not at S45 (gel 3) (compare lanes 1 and 3). -catenin (Flag) was
expressed alone (control, lane 1) or coexpressed with GSK-3 (lane 2) or GSK-3KM (lane 3) in Xenopus embryos and precipitated by a Flag
Ab (panel 4). -catenin phosphorylation was examined via blotting the precipitates with indicated Abs.
(B and C) LiCl- and Wnt-1-inhibited phosphorylation at S33/S37/T41, but not at S45 of the endogenous -catenin in Rat2 cells. Cells were
treated with (B) LiCl- (final concentration 20 mM) or with (C) Wnt-1-conditioned medium. Cytosolic extracts were prepared at indicated time
points and analyzed for -catenin protein level (top), phosphorylation at S33/S37/T41 (middle), or at S45 (bottom) via immunoblotting. Either
LiCl or Wnt-1 increased -catenin level. In the two graphs, -catenin S33/S37/T41 or S45 phosphorylation is presented as a ratio between
phosphorylation versus -catenin protein level. The starting ratio at the control point (0 min) was set at 1 for both curves, which represented
averages of at least three independent experiments.
that, in vivo, mutations at T41 and S45 also prevented S45 mutation abolished S33 and S37 phosphorylation
(Figure 1F). By contrast, neither S33 nor S37 mutation-Trcp binding to -catenin in a manner indistinguish-
able from mutations at S33 and S37 (Figure 1C). These affected T41 or S45 phosphorylation (Figure 1F). Fur-
thermore, T41 mutation did not effect S45 phosphoryla-results explain why each of these mutations leads to
deregulated -catenin stabilization in cancer cells and tion, but the S45 mutation prevented T41 phosphoryla-
tion (Figure 1F). These results suggest that -cateninfurther suggest that T41 and S45 may play a critical
regulatory role in -catenin phosphorylation and/or phosphorylation in vivo occurs in the carboxy- to amino-
terminal direction, starting from S45 to T41, and then to-Trcp/-catenin interaction. One possibility is that
-catenin phosphorylation at S33 and S37 depends on S37 and S33, and the prior phosphorylation event is
necessary for subsequent phosphorylation events toT41 and S45 phosphorylation, and this dependency is
lost in vitro when excess GSK-3 is provided. Indeed, occur.
some in vitro studies suggest that GSK-3 is a processive
kinase that sequentially phosphorylates S/T pentad- -Catenin Phosphorylation by GSK-3
and an “S45” Kinase In Vivorepeats from the carboxy- to amino-terminal direction
(Harwood, 2001; Woodgett, 2001; Cohen and Frame, We then examined whether GSK-3 is responsible for
S45, T41, S37, and S33 phosphorylation. Others and we2001).
To examine how -catenin is phosphorylated in vivo, have shown that the dominant-negative GSK-3 mutant,
GSK-3KM, mimics, whereas the wild-type GSK-3 antag-we generated a panel of antibodies (Abs) that specifi-
cally recognize -catenin phosphorylated at different onizes, Wnt/-catenin signaling (Pierce and Kimelman,
1995; Dominguez et al., 1995; He et al., 1995). Indeed,S/T residues (Figures 1D and 1E). Ab(3337) detects
phosphorylation at both S33 and S37; so does Ab we found that GSK-3 enhanced, whereas GSK-3KM in-
hibited, T41, S37, and S33 phosphorylation (Figure 2A).(3337)/41, which, in addition, also detects T41 phos-
phorylation to some extent. Ab(41/45) recognizes phos- Surprisingly, neither GSK-3 nor GSK-3KM had any effect
on S45 phosphorylation (Figure 2A), implying that S45phorylation at either T41 or S45; Ab41 recognizes
phosphorylated T41, and Ab45 detects phosphorylated is phosphorylated by a distinct kinase, which likely rep-
resents a so-called priming kinase (Harwood, 2001;S45 (Figures 1D and 1E; see Supplemental Figure S1 at
http://www.cell.com/cgi/content/full/108/6/837/DC1). Woodgett, 2001; Cohen and Frame, 2001). Although
GSK-3 phosphorylation of some substrates, such asWe found that, in vivo, while the wild-type -catenin
was phosphorylated at both S33 and S37, either T41 or glycogen synthase, requires priming phosphorylation, it
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is widely believed that the proximity of -catenin and with Axin(catS45K) (Figure 3A), which contains the
S45 phosphorylation stimulatory activity, suggestingGSK-3 in the Axin complex forfeits priming phosphoryla-
tion (reviewed in Weston and Davis, 2001; Cohen and that S45 kinase indeed binds to Axin. We fractionated
the S45 kinase activity by sequential chromatographyFrame, 2001).
We further examined whether phosphorylation of S45 via SP- and Blue-Sepharose columns (Figures 4E and
4F). Silver staining of the eluted fractions from the Blue-and T41/S37/S33 of the endogenous -catenin is differ-
entially regulated. LiCl is a potent GSK-3 inhibitor (Stam- Sepharose column identified a protein band of about 37
kDa that correlated with the S45 kinase activity (Figurebolic et al., 1996; Hedgepeth et al., 1997) and indeed
suppressed T41/S37/S33 but not S45 phosphorylation 4F). Further, this 37 kDa protein band could be depleted
by Axin(catS45K) that depleted the S45 kinase activ-(Figure 2B). Wnt signaling is suggested to inhibit GSK-3
phosphorylation of -catenin, and indeed, Wnt-1-condi- ity (Figure 4G). Mass spectrum analysis of the excised
37 kDa band revealed six peptide fragments that showtioned medium blocked T41/S37/S33, but not S45,
phosphorylation (Figure 2C). These results provided in perfect matches to the serine/threonine kinase CKI
(Figure 4H). Indeed, immunoblotting demonstrated thatvivo evidence and kinetics for Wnt inhibition of GSK-3
phosphorylation of -catenin and further supported the CKI, which is 37 kDa, was copurified with the S45
kinase activity (Figure 4F) and was depleted by Axin-existence of a “S45” kinase, whose regulation is distinct
from that of GSK-3. (catS45K) (not shown).
CKI Is Essential for -Catenin PhosphorylationStimulation of S45 Kinase Activity by Axin
We next examined how S45 phosphorylation can be Degradation
We first confirmed that CKI is a component of the Axinmodulated. Axin is a scaffolding protein that assembles
a multiprotein complex devoted to -catenin phosphor- complex. We immunoprecipitated either overexpressed
or the endogenous Axin from mammalian cells and de-ylation/degradation (Figure 3A; Kikuchi, 1999). Interest-
ingly, we found that expression of Axin stimulated phos- tected the endogenous CKI (and GSK-3) associated
with Axin (Figures 5A and 5B). Further, Axin(catS45K)phorylation of S45 and T41/S37/S33 (Figure 3B), implying
that the S45 kinase, like GSK-3, may be a component but not Axin(cat) precipitated the endogenous CKI
(Figure 5C). We next examined whether CKI is able toof the Axin complex. We mapped the Axin domain that
harbors the stimulatory activity for S45 phosphorylation. phosphorylate -catenin at S45 in vivo. Expression of
CKI increased S45 phosphorylation, whereas expres-Neither the RGS domain, which mediates Axin-APC as-
sociation, nor the DIX domain, which is involved in Axin sion of a related but distinct member of the CKI family,
CKI, did not (Figure 5D). We then asked whether CKIinteraction with Dishevelled (Li et al., 1999; Itoh et al.,
2000; Salic et al., 2000) and with the Wnt coreceptor is required for S45 phosphorylation in vivo. We depleted
the endogenous CKI protein in 293T cells via double-LRP5/6 (Mao et al. 2001), was required for S45 phos-
phorylation (Figures 3A–3C). Importantly, the GSK3 strand (ds) RNA-mediated interference (RNAi; Elbashir
et al., 2001). A ds RNAi oligo for CKI significantly re-binding domain of Axin was also dispensable for S45
phosphorylation (Figures 3A and 3C). By contrast, dele- duced the amount of CKI protein (Figure 6A) and inhib-
ited S45 phosphorylation (Figure 6B). CKI RNAi alsotion of Axin’s -catenin binding domain (Axincat) or
the adjacent carboxyl region (AxinS45K) severely di- inhibited -catenin S33/S37/T41 phosphorylation (Fig-
ure 6C), which depends on S45 phosphorylation. Mostminished the ability of Axin to promote -catenin S45
phosphorylation (Figures 3A and 3C). In fact, the Axin significantly, CKI RNAi resulted in significant -catenin
protein accumulation (Figure 6D). CKI RNAi did notfragment that contains the -catenin binding domain
plus the adjacent carboxyl domain, Axin(catS45K), alter the protein level of CKI, GSK-3 and GSK-3 (Fig-
ures 6E and 6F), or tubulin (not shown), demonstratingwas sufficient to stimulate S45 phosphorylation, where-
as the Axin fragment containing solely the -catenin the specificity of RNAi and further supporting the notion
that reduction of S33/S37/T41 phosphorylation by CKIbinding domain, Axin(cat), was not (Figures 3A and
3D). These results suggest that, in addition to recruiting RNAi was due to inhibition of S45 phosphorylation. As
a negative control, the single-strand sense RNAi oligoGSK-3 and -catenin together, Axin may also bring the
S45 kinase into the proximity of -catenin, thereby pro- had little effect on CKI protein amount, -catenin S45
phosphorylation, and the protein level (Figures 6A–6F).moting sequential phosphorylation of -catenin by the
S45 kinase and GSK-3. CKI was recently shown to stimulate -catenin sig-
naling (Peters et al., 1999; Sakanaka et al., 1999), thus
functioning in a manner that is opposite to that of CKI.Identification of the S45 Kinase as Casein
We also depleted CKI via a ds RNAi oligo, which signifi-Kinase I (CKI)
cantly reduced the protein level of CKI, but not of CKIWe set out to purify the S45 kinase from rat brain ex-
or tubulin (Figures 6G–6I). Contrary to depletion of CKI,tracts, which exhibited strong S45 kinase activity (Figure
depletion of CKI exhibited no effect on -catenin phos-4A). This activity was not depleted by an affinity col-
phorylation or protein level (Figures 6J–6L). Thus, CKIumn composed of -catenin (thus, does not bind to
and CKI have distinct functions in -catenin signaling.-catenin), or of the Axin fragment containing the GSK-3
binding domain, Axin(G3cat) (Figure 3A), which de-
pleted both isoforms of GSK-3,  and , from the brain CKI Is a Segment Polarity Gene in Drosophila
Wnt/-catenin signaling is conserved from Drosophilaextract (Figures 4A–4C). Thus, the S45 kinase is again
distinct from GSK-3. By contrast, the S45 kinase activity to human (Wodarz and Nusse, 1998; Moon et al., 1997).
We thus examined whether CKI regulates degradationwas significantly diminished (Figure 4D) by depletion
Casein Kinase I in -Catenin Phosphorylation
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Figure 3. Stimulation of S45 Phosphorylation by Axin
(A) Axin and Axin mutants. Axin’s binding regions for APC (the RGS domain), GSK-3, -catenin, Dishevelled (Dvl), and LRP5/6 (the DIX domain)
and the putative S45 kinase are indicated on top.
(B) Axin expression stimulated phosphorylation at S45 (middle gel) and S33/S37/T41 (top gel). -catenin (Flag) was expressed alone (control)
or together with Axin or AxinRGS (Myc) in Xenopus embryos and precipitated by a Flag Ab (bottom gel). -catenin phosphorylation was
examined by blotting the precipitates with indicated Abs.
(C) Axin’s -catenin binding region and the adjacent carboxyl region are required for stimulating S45 phosphorylation. -catenin (S33Y) mutant
(Flag) was used for analysis because the mutation does not affect S45 phosphorylation, and -catenin (S33Y) protein level is constant
regardless of coexpressed Axin or mutants. Deletion of Axin’s binding regions for APC, GSK-3, Dishevelled, and LRP5/6 did not affect the
ability of Axin to stimulate S45 phosphorylation, but deletion of either Axin’s -catenin binding region or the adjacent carboxyl region abolished
Axin’s ability to stimulate S45 phosphorylation (top gel). The protein expression level for the wild-type Axin is always lower than that for Axin
mutants.
(D) Axin’s -catenin binding region plus the adjacent carboxyl region are sufficient for stimulating S45 phosphorylation. Deletion of the adjacent
carboxyl region abolished the activity (top gel). In (C) and (D), -catenin (S33Y) (Flag) was expressed alone (control) or coexpressed with Axin
or Axin mutants (Myc) in Xenopus embryos and precipitated by a Flag Ab (bottom gel). Precipitates were examined for S45 phosphorylation
(top gel). Axin and its mutants in embryo extracts were examined via a Myc Ab (middle gel).
of Armadillo (Arm), the Drosophila ortholog of -catenin. did not affect Arm amount (Figure 7A) or the cuticle
phenotype (not shown), demonstrating the specificity ofStrikingly, RNAi depletion of Drosophila CKI resulted
in a dramatic increase of Arm protein in S2 cells (Figure CKI depletion. Arm protein accumulation in S2 cells
and the segment polarity phenotype in embryos resulted7A). Furthermore, RNAi depletion of CKI in Drosophila
embryos generated a naked cuticle phenotype (Figure from CKI RNAi, therefore, suggest together that CKI
function is conserved and essential for -catenin degra-7B) and a strong expansion of the expression domain
of wingless (wg, Drosophila wnt-1; Figure 7C), which dation in both Drosophila and human.
itself is an Arm target gene. This is reminiscent of the
phenotype caused by loss-of-function mutations in Dro- Discussion
sophila Axin (Hamada et al., 1999; Willert et al., 1999)
or GSK-3 (zeste-white 3/shaggy) gene (Siegfried et al., We provided compelling evidence that -catenin phos-
phorylation in vivo is sequentially carried out by two1994) or by wg overexpression (Noordermeer et al.,
1992). CKI RNAi did not alter the level of other proteins distinct kinases, CKI and GSK-3. CKIphosphorylation
of S45 proceeds and is required for subsequent GSK-3such as tubulin, and RNAi for other unrelated genes
Cell
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Figure 4. Identification of the S45 Kinase as CKI
(A–C) Identification in rat brain extracts an S45 kinase activity that is independent of GSK-3.
(A) In an in vitro kinase assay, the rat brain extract phosphorylated GST-N3 (the -catenin amino-terminal region containing S33, S37, T41,
and S45; Liu et al., 1999) at S45 as detected by blotting GST-N3 with Ab45. This S45 kinase activity was not depleted by GST, GST--catenin,
or GST-Axin(G3cat). Control indicates no brain extracts added.
(B and C) GST-Axin(G3cat) depleted both GSK-3 and GSK-3 from the brain extract, as assayed by blotting with Abs that recognize both
GSK-3 (top) and GSK-3 (bottom) (B), and by in vitro phosphorylation with [32P]ATP of a GSK-3 substrate peptide (with the primed phosphate)
derived from glycogen synthase (GS) (C).
(D) The brain S45 kinase activity was significantly depleted by GST-Axin(catS45K). S45 phosphorylation on GST-N3 in the in vitro kinase
assay was examined with Ab45.
(E) Fractionation of the S45 kinase in the brain extract via a SP-Sepharose column. All S45 kinase activity, but less than 10% of the total
protein, bound to the column after initial loading. Elution was done with increasing NaCl concentrations (0.15 M for fractions 1–57, 0.3 M for
fractions 58–97, and 2M for the remaining fractions). Fractions were pooled as shown and analyzed for S45 kinase activity (bottom gel) as
done in (A). The highest S45 kinase activity was eluted into fractions 88–97, which had lowest protein levels as reflected by OD 280 nm (top
graph).
(F) Fractions 88–97 from the SP-Sepharose column were pooled together and fractionated using a Blue-Sepharose column. All S45 kinase
activity was retained by the column, which was sequentially washed with increasing concentrations of NaCl with or without 5 mM ATP as
indicated. Different fractions were collected and subjected to silver staining (top gel) and in vitro S45 kinase assay (middle gel) as done in
(A). The kinase activity was eluted at 0.7 M NaCl with or without ATP, and correlated fully with the appearance of a 37 kDa band. The bottom
gel shows CKI immunoblotting, performed after the identification of the 37 kDa band as CKI.
(G) GST-Axin(catS45K) but not GST depleted the 37 kDa band and the S45 kinase activity from fractions 88–97 of the SP-Sepharose
column, as visualized by silver staining (top gel) and the in vitro S45 kinase assay (bottom gel) done as in (A).
(H) The 37 kDa band from the gel contained a single kinase, CKI (and several other proteins) as revealed by mass spectrum analysis.
Underlined peptide sequences were perfect matches between mass spectra of the band (trypsin-digested) and CKI.
phosphorylation of T41, S37, and S33 (Figure 8). Our tions causes -catenin to escape recognition by -Trcp
and subsequent degradation (Figure 8).findings identify CKI as an essential component that
controls -catenin phosphorylation degradation. This CKI was among the first protein kinase activities
discovered, yet its function and regulation remainsunderstanding of -catenin phosphorylation at a single-
residue resolution enables us to look into how -catenin poorly understood. Like GSK-3, CKI is expressed ubiq-
uitously and appears to be constitutively active (Grossmutations found in human cancers disrupt distinct steps
in -catenin degradation. Thus, mutations surrounding and Anderson, 1998), consistent with its role in-catenin
degradation. The finding that -catenin is a CKI sub-S33 and S37 abolish -catenin recognition by -Trcp
and the ubiquitination of -catenin; mutations at T41 strate in vivo therefore identifies CKI as a central player
in cell fate determination and growth control. Indeed,prevent GSK-3 phosphorylation of S37 and S33 and
thus -Trcp recognition; and mutations at S45 block the CKI controls segment polarity during Drosophila em-
bryogenesis (Figure 7). Interestingly, -catenin phos-priming phosphorylation by CKI and consequently all
phosphorylation events by GSK-3. Each of these muta- phorylation by CKI and by GSK-3 are both stimulated
Casein Kinase I in -Catenin Phosphorylation
843
Figure 5. CKI Is a Component of the Axin
Complex and Promotes -Catenin S45 Phos-
phorylation
(A) Overexpressed Axin (Myc) precipitated
the endogenous CKI and GSK-3 in
293T cells. Immunoprecipitation (IP) was
done with a Myc Ab. Control indicates mock
transfection.
(B) The endogenous Axin precipitated the en-
dogenous CKI and GSK-3 in mouse L cells.
IP was done with Axin Abs (which only recog-
nize mouse/rat Axin) or a Myc Ab (control).
(C) Transfected Axin(catS45K) but not
Axin(cat) (both Myc-tagged) precipitated
the endogenous CKI in 293T cells. Neither
precipitated GSK-3. IP was done with a Myc
Ab. In (A)–(C), precipitates were blotted with
Abs for GSK-3, CKI, or Axin, or Myc (for tagged Axin). Only GSK-3 was shown, since GSK-3 and IgG (both 50 kDa) were not resolved on
the gel.
(D) Overexpression of CKI, but not CKI, increased -catenin S45 phosphorylation. Likely as a consequence, CKI also increased S33/S37/
T41 phosphorylation. -catenin (Flag) cDNA was transfected alone (control, C) or together with CKI or CKI cDNA. Cell extracts were made
2 days after transfection and immunoblotted with indicated Abs.
by Axin (Figure 3). In fact, CKI and GSK-3 bind to inhibits GSK-3 phosphorylation of, and thereby acti-
vates, glycogen synthase (GS) (Harwood, 2001; Wood-different regions of Axin such that they “sandwich”
-catenin in the Axin complex, thereby promoting effec- gett, 2001; Frame et al., 2001). GSK-3 is thus a major
therapeutic target for treating type II or non-insulin-tive -catenin phosphorylation (Figures 3A and 8). As
Wnt signaling inhibits only GSK-3 but not CKI phos- dependent diabetes mellitus (NIDDM), which accounts
for 90% of all diabetes cases. Insulin and Wnt inhibitphorylation of -catenin (Figure 2), CKI may represent
a node at which other signaling pathways regulate GSK-3 phosphorylation of GS and -catenin, respec-
tively. This specificity appears to depend, at least in-catenin protein level. As depletion of CKI causes
-catenin accumulation in a manner similar to a lack of part, on whether GSK-3 is inhibited via phosphorylation
by Akt upon insulin signaling (Cross et al., 1995; Dajanifunction of GSK-3, APC, or Axin (Figures 6 and 7), CKI
is a candidate tumor suppressor. et al., 2001; Frame et al., 2001) or via Dishevelled and
GBP (GSK-3 binding protein) binding to GSK-3 and AxinA priming kinase for GSK-3 in -catenin phosphoryla-
tion is not fully expected. Besides Wnt signaling, GSK-3 upon Wnt signaling (Li et al., 1999; Ding et al., 2000; Farr
et al., 2000; Salic et al., 2000). While GSK-3 phosphoryla-is also a key enzyme in insulin signal transduction, which
Figure 6. CKI Is Essential for -Catenin S45
Phosphorylation and Degradation in 293T
Cells
(A–F) CKI RNAi (Ri) decreased the CKI pro-
tein level (A), -catenin S45 phosphorylation
(B), and S33/S37/T41 phosphorylation (C),
but increased -catenin protein level (D).
Note that graphs in (B) and (C) reflect the ratio
between -catenin phosphorylation versus
-catenin protein level. CKI RNAi did not
affect the protein level for CKI (E), GSK-3
and GSK-3 (F), or tubulin (not shown).
(G–L) CKI RNAi (Ri) decreased the protein
level of CKI (G) but not of CKI (H) or tubulin
(I), but had no effect on -catenin S45 phos-
phorylation (J), S33/S37/T41 phosphorylation
(K), or -catenin protein level (L). Cell extracts
were made 3 days after transfection with the
double-strand (ds) RNAi oligo (Ri) or the cor-
responding single-strand sense oligo (S, as
a negative control). C (control) indicates with-
out RNAi transfection or with mock transfec-
tion. Graphs represent averages from at least
four independent experiments, with the value
for the control set as 1 arbitrarily.
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Figure 7. Drosophila CKI Is Required for Armadillo (Arm) Degradation and Segment Polarity
(A) CKI RNAi induced Arm accumulation. S2 cells were either untreated (control, C), or treated with ds RNA for Drosophila CKI (Ri) or for
Xenopus -Trcp (Ci, a negative control). The cytoplasmic or total cell extract was made 3 days after RNAi treatment and immunoblotted with
an Ab for Arm or tubulin.
(B) Drosophila embryo injected with CKI ds RNA (bottom) exhibited a naked cuticle phenotype. A total of 109 of 460 CKI-RNAi injected
embryos (24%), but none of the 64 embryos injected with buffer alone (top), exhibited the phenotype shown.
(C) CKI-RNAi-injected embryos (bottom) exhibited an expansion of the wg expression domain when compared with the wild-type embryo
(top), as assayed by whole-mount in situ hybridization at stage 13.
tion of GS requires priming phosphorylation and occurs comes of GSK-3 inhibition by insulin versus by Wnt
(Thomas et al., 1999; Frame et al., 2001). In fact, a strat-without the assistance of any scaffolding protein, GSK-
3 and -catenin are placed next to each other by Axin, egy for therapeutic inhibition of GSK-3 in treating NIDDM
is based on the assumption that inhibitors specific forwhich stimulates -catenin phosphorylation by GSK-3
in vitro (Kikuchi, 2000). It is thus widely believed that GSK-3 phosphorylation of primed GS could be devel-
oped that would not inhibit GSK-3 phosphorylation ofthe Axin-GSK-3--catenin complex bypasses the re-
quirement for priming phosphorylation (reviewed in nonprimed -catenin and thus would not induce
-catenin accumulation and cancer. Our data revealWeston and Davis, 2001; Cohen and Frame, 2001). Some
studies using in vitro kinase assays suggest that the that, like GS, -catenin phosphorylation by GSK-3 also
requires a critical priming step and thus suggests a needintrinsic property of GSK-3 to differentially phosphory-
late primed (such as GS) versus “nonprimed” (such as to reevaluate our thinking on the specificity of GSK-3
inhibition by insulin and Wnt and on therapeutic drug-catenin) substrates may underlie the distinct out-
design for GSK-3 activity.
The observation that GSK-3 phosphorylation of its
major physiological substrates, GS and -catenin, de-
pends on priming kinases is fully consistent with recent
analyses of the GSK-3 atomic structure (Dajani et al.,
2001; ter Haar et al., 2001) and further raises the question
whether GSK-3 phosphorylation of most, if not all, sub-
strates requires priming phosphorylation. In vitro, GSK-3
can phosphorylate other components in the Wnt path-
way, including APC (Rubinfeld et al., 1996), Axin (Yama-
moto et al., 1999; Jho et al., 1999; Willert et al., 1999),
and TCF (Lee et al., 2001). GSK-3 phosphorylation of
APC (Rubinfeld et al., 1996) and Axin enhances their
ability to bind to -catenin and stabilizes Axin protein
(Yamamoto et al., 1999; Jho et al., 1999; Willert et al.,
1999), all contributing to -catenin degradation. It will
be important, therefore, to examine whether GSK-3
phosphorylation of APC, Axin, or TCF in vivo requires
priming phosphorylation, and whether CKI and/or
other kinases serve as the priming kinase(s) for these
substrates. It is also of interest to note that GSK-3 phos-
phorylation of different substrates requires distinctFigure 8. A Model for -Catenin Phosphorylation and Recognition
by -Trcp priming kinases (casein kinase II for GS, CKI for
CKI, GSK-3, and -catenin each bind a different domain of Axin -catenin, and protein kinase A for CREB). These dual-
such that CKI and GSK-3 sandwich -catenin in the Axin complex. kinase systems may provide exquisite combinatory con-
CKI phosphorylation of S45 allows GSK-3 to phosphorylate T41, trol for GSK-3 substrate selectivity.
then S37 and S33. Phosphorylation of S37 and S33 creates the
Another member of the CKI family, CKI, has beenrecognition site for -Trcp. Wnt signaling inhibits GSK-3 phosphory-
shown to stimulate -catenin signaling (Peters et al.,lation of T41, S37, and S33. How CKI phosphorylation of S45 is
regulated remains unknown. 1999; Sakanaka et al., 1999), and thus it functions in a
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anti-Flag (M2) (Sigma); anti-Myc (9E10); anti-Arm (7A1); and anti-manner that is opposite to that of CKI. CKI and CKI
tubulin (E7, from Developmental Studies Hybridoma Bank, Univer-share related kinase but different flanking domains and
sity of Iowa). GSK-3 Abs were described (He et al., 1995; kindlyhave been known to exhibit distinct functions (Gross
provided by J. Woodgett). Immunoprecipitation, SDS-PAGE, and
and Anderson, 1998). For example, CKI, but not CKI, immunoblotting were done as described (Liu et al., 1999).
rescues growth arrest in a yeast mutant deficient for
Hrr25, a CKI homolog (Fish et al., 1995). We found that Xenopus laevis Embryo Manipulations
only CKI, but not CKI, is capable of phosphorylating Synthetic RNAs for each tested protein were injected at 1 ng/embryo
-catenin at S45 (Figure 5D). Importantly, depletion of into the animal pole at the 2-cell stage. Whole embryo extracts
were made at stage 8 for analyses. Procedures for embryo staging,CKI, but not CKI, prevents -catenin phosphorylation
injection, and extracts were described (Liu et al., 1999).and degradation (Figure 6). In addition, CKI fails to
compensate for CKIdepletion and the consequent inhi-
Protein Purification and Mass Spectrum Analysisbition of -catenin phosphorylation (Figure 6). Previous
Adult rat brains (200 grams) were homogenized in 450 ml of homoge-experiments also demonstrated that CKI, but not CKI,
nization buffer (HB, 50 mM HEPES [pH 7.4], 10 mM NaF, plus thecan activate -catenin signaling in mammalian cells and
protease inhibitor cocktail [Roche]) using a Polytron Homogenizer.
Xenopus embryos (Sakanaka et al., 1999). However, one The homogenate was centrifuged at 10,000 	 g for 30 min at 4
C.
study suggests that CKI and CKI can each activate The supernatant yielded the brain extract (BE) and was used as the
starting material for purification, depletion, or in vitro kinase assays.Wnt signaling upon overexpression in Xenopus embryos
S45 kinase assay was performed as described (Liu et al., 1999),(McKay et al., 2001). We speculate that inherent short-
using GST-N3 as the substrate and Ab45 for phospho-S45 detection.comings of certain overexpression experiments may ac-
The primed GS peptide was used as the substrate for GSK-3 in BEcount for this discrepancy. It remains unclear how CKI
with [32P]ATP (He et al., 1995). BE (10l) was used in a kinase reaction
functions positively in -catenin signaling. CKI has (40 l final volume). For depletions, 200 l BE were incubated at
been shown to bind Dishevelled (Peters et al., 1999; 4
C for 2 hr with 50 l of glutathione-agarose beads bound by 5 g
GST-fusion proteins. After precipitation, 10 l supernatant was usedSakanaka et al., 1999), Axin (Sakanaka et al., 1999), and
for kinase assays.TCF (Lee et al., 2001) and can phosphorylate Dishevelled
For purification, BE was applied onto a 25 cm 	 2.5 cm SP-(Peters et al., 1999), APC (Rubinfeld et al., 2001), and
Sepharose (Amersham Pharmacia) column equilibrated with HB. ATCF (Lee et al., 2001) but not -catenin (Peters et al.,
S45 kinase activity was eluted when NaCl concentration was above
1999). As such, CKI may modulate the binding of 0.15 M, with maximal elusion at 0.3 M. Fractions 88–97 had the
Dishevelled to GBP, of -catenin to TCF (Lee et al., highest specific kinase activity and were pooled together (total 100
ml) for storage at 80
C. A volume of 12 ml was further fractionated2001), or of other components to the Axin complex (Gao
via a 1 ml Blue-Sepharose column (Amersham Pharmacia) preequili-et al., 2002). Identification of the in vivo substrate(s) of
brated with 0.3 M NaCl in HB. Bound proteins were eluted withCKIwill elucidate further how CKI proteins play distinct
stepwise increases of NaCl with or without ATP. Mass spectrumroles in Wnt signal transduction.
analysis was done at the Taplin Mass Spectrometry Facility at Har-
vard Medical School according to standard procedures.
Experimental Procedures
Mammalian Cell Transfection, Extracts, and RNAiPlasmids
Transfections were done with Lipofectamine (Invitrogen) onThe following plasmids were described: CS2-catenin (Flag),
293T cells in 6-well plates. Expression plasmids were transfectedpGEX--catenin, and CS2-Trcp (Myc) (Liu et al., 1999); SP64-
each at 1 g/well. ds RNAi oligos and single-strand sense oligosGSK-3 and SP64-GSK-3KM (He et al., 1995); CS2Axin and
were transfected at 2.5 g/well. These were designed as describedCS2AxinRGS (both Myc-tagged) (Zeng et al., 1997); and
(Elbashir et al., 2001) and synthesized by Integrated DNA Tech., Inc.CS2CKI (Peters et al., 1999). Rat CKI was subcloned into CS2.
These were CKI (human, sense), 5-CCAGGCAUCCCCAGUUGSubstitutions or deletions in -catenin and Axin were generated by
CUTT-3; CKI (human, sense), 5- UGGCCAAGAAGUACCGGGATT-the QuickChange Kit (STRATAGENE). AxinG3, Axincat, Axin
3. ds RNA oligos were annealed in vitro before transfection. ForS45K, and AxinDix correspond to deletions of residues 357–526,
cytosolic extracts, cells were washed in cold PBS, collected in 1 ml526–722, 619–903, and 903–992, respectively, of mouse Axin (Zeng
PBS (with protease and phosphotase inhibitors), and homogenizedet al., 1997). Axin(G3cat), Axin(catS45K), and Axin(cat) corre-
by a Dounce homogenizer. Lysates were centrifuged at 15,000 rpmspond to mAxin residues 357–724, 526–903, and 526–722, respec-
for 30 min at 4
C, and the supernatant was collected.tively. The corresponding cDNA fragments were cloned in CS2Myc
and/or pGEX for GST-fusion proteins.
RNAi in Drosophila S2 Cells and Embryos
RNAi in S2 cells was performed as described (Clemens et al., 2000).Antibodies, Immunoprecipitation, and Immunoblotting
Rabbit polyclonal antibodies (Abs) were generated via standard pro- Following DNA primers were used: 5-GAATTAATACGACTCACTA
TAGGGAGAGGCCATCAAGATGGAGAGC-3 and 5-GAATTAATACcedures using the following synthetic phosphopeptides as immuno-
gens: SYLDS*GIHS*GATT*TAPC (S* or T*: phospho-S or -T), gener- GACTCACTATAGGGAGACATGTAATCTGGCTGCTCC-3 (Drosoph-
ila CKI); 5-TAATACGACTCACTATAGGGAGACCACGTCCGGACAating Ab(3337)/41; CSYLDS*GLHS*GAT, generating Ab(3337);
CGATT*TAPS*KSGKG, generating Ab41/45 and Ab45; and CGATT* GATTCTCTTTG-3 and 5-TAATACGACTCACTATAGGGAGACCA
CAGCAAGTCCTGGGTCGTTG-3 (Xenopus -Trcp). Briefly, in vitroTAPSLSGKGNPE, generating Ab41. Bleeds were passed three times
through a nonphosphopeptide column to remove Abs that recog- transcribed RNA complementary strands were annealed and added
at 15 g/well to S2 cells in 1 ml serum-free medium for 30 min.nized the peptide without phosphorylation. The final flowthrough
was loaded onto a phosphopeptide column, which was washed Regular medium with serum (2 ml) were then added, and cells were
cultured for 3 days. Total cell lysates were made by spinning 0.5three times with 0.1 M Tris buffer (pH 8.0). Bound Abs were eluted
with 0.1 M Glycine (pH 2.5) and neutralized with 1 M Tris buffer. Ab41/ ml cells at 1,000 	 g and dissolving the pellet in 50 l 1	 SDS
loading buffer. Cytosolic extracts were made as for mammalian45 was further passed three times through a column composed of
phospho-T41 peptide to remove Abs that recognized phospho-T41, cells.
For RNAi in Drosophila embryos, the wild-type precellular embryoand the final flowthrough yielded Ab45.
Other Abs were used according to suppliers’ instructions: poly- was injected with 3 M CKI dsRNA or buffer as described (Kenner-
dell and Carthew, 1998). Embryos were incubated at 18
C under oilclonal anti--catenin (C2206, Sigma); anti-CKI (Santa Cruz Biotech-
nology); anti-CKI (C40520, Transduction Laboratories); monoclonal for 2 days and were mounted in Hoyer’s medium/lactic acid for
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cuticle preparations. Whole-mount in situ hybridization was done organization and positioning of a multifunctional protein kinase fam-
ily. Cell. Signal. 10, 699–711.as described (Lehmann and Tautz, 1994).
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